ammonium tungsten antimonate hydroxide oxide has been researched along with Enlarged Spleen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augery, Y; Chermann, JC; Degiorgis, V; Jasmin, C; Larnicol, N; Le Bousse-Kerdiles, C; Teze, A | 1 |
| Boy-Loustau, C; Chermann, JC; Herve, G; Jasmin, C; Raybaud, N; Raynaud, M; Sinoussi, F; Souchay, P; Teze, A | 1 |
2 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and Enlarged Spleen
| Article | Year |
|---|---|
In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia.
Topics: Animals; Antimony; Antiviral Agents; Erythropoiesis; Friend murine leukemia virus; Leukemia, Experimental; Mice; Splenomegaly; Time Factors; Tungsten; Tungsten Compounds | 1981 |
In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.
Topics: Animals; Antigens, Viral; Antimony; Antiviral Agents; Friend murine leukemia virus; Gammaretrovirus; Immunization; Interferon Inducers; Leukemia L1210; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Moloney murine leukemia virus; Sarcoma; Sarcoma, Experimental; Splenomegaly; Tungsten; Tungsten Compounds | 1974 |